CUE BIOPHARMA – Trademark Portfolio

Entity Type: 03

CUE BIOPHARMA holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CUE BIOPHARMA. The owner is based in Cambridge, MA.

21 Erie Street

Cambridge, MA 02139

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CUE BIOPHARMA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does CUE BIOPHARMA have?

CUE BIOPHARMA has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does CUE BIOPHARMA file in?

CUE BIOPHARMA files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CUE BIOPHARMA's most well-known trademarks?

CUE BIOPHARMA's registered trademark portfolio includes well-known marks such as CUE BIOPHARMA. These are among 1 currently registered trademark in the portfolio.

What is CUE BIOPHARMA's trademark registration success rate?

CUE BIOPHARMA has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.